Celsis International plc, the life sciences products and services company, will today hold its Annual General Meeting. Dr Jack Rowell, Non Executive Chairman of Celsis, will make the following comments: “In the year ended 31 March 2006, Celsis delivered another strong set of financial results, reporting double digit organic profit growth and a substantial increase in revenues. The current financial year has started well and I can report that the integration of In Vitro Technologies (IVT) is progressing well following completion of the acquisition.
